EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Real‐world tolerance of sublingual immunotherapy for aeroallergens in severe allergic asthmatic children controlled on omalizumab

François Maury, Caroline Dufrois, Nathalie Lambert, Mélisande Bourgoin-Heck iD, Stéphanie Wanin iD

Pediatric Allergy and Immunology · 2026-11 · 37 (11)

DOI: 10.1111/pai.70523 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Allergy and Immunology, online erschienen am 02.11.2026. Verfasst von François Maury und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Allergology, Armand Trousseau University Hospital, Groupe Hospitalier Universitaire, AP-HP Sorbonne-University, Paris, France. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

allergenic immunotherapybiologicchildomalizumabsevere asthma

Autor:innen und Institutionen

  • Department of Pediatric Allergology, Armand Trousseau University Hospital, Groupe Hospitalier Universitaire, AP-HP Sorbonne-University, Paris, France.

ORCID-Profile: Mélisande Bourgoin-Heck, Stéphanie Wanin

Zitieren

APA

Maury, F., Dufrois, C., Lambert, N., Bourgoin-Heck, M., & Wanin, S. (2026). Real‐world tolerance of sublingual immunotherapy for aeroallergens in severe allergic asthmatic children controlled on omalizumab. Pediatric Allergy and Immunology, 37(11). https://doi.org/10.1111/pai.70523

Vancouver

Maury F, Dufrois C, Lambert N, Bourgoin-Heck M, Wanin S. Real‐world tolerance of sublingual immunotherapy for aeroallergens in severe allergic asthmatic children controlled on omalizumab. Pediatric Allergy and Immunology. 2026;37(11). doi:10.1111/pai.70523

BibTeX
@article{Maury2026,
  author = {Maury, François and Dufrois, Caroline and Lambert, Nathalie and Bourgoin-Heck, Mélisande and Wanin, Stéphanie},
  title = {Real‐world tolerance of sublingual immunotherapy for aeroallergens in severe allergic asthmatic children controlled on omalizumab},
  journal = {Pediatric Allergy and Immunology},
  year = {2026},
  volume = {37},
  number = {11},
  doi = {10.1111/pai.70523}
}
Kostenlos starten →